Day: October 24, 2025

NANO Nuclear Energy Inc.NANO Nuclear Energy Holds Milestone Ceremony to Mark Beginning of Drilling Work for First KRONOS MMR™ Micro Modular Reactor Energy System in Partnership with University of Illinois.Tune in today via webcast at 11:30 am Eastern to hear from management, key commercial stakeholders, university officials and distinguished guests as NANO Nuclear celebrates the commencement of real-world work on its micro modular reactor prototype New York, N.Y, Oct. 24, 2025 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today is holding a milestone ceremony at the University of Illinois Urbana-Champaign (U. of I.) for the research and commercial prototype of its...

SHENZHEN, China, Oct. 24, 2025 (GLOBE NEWSWIRE) — Fangdd Network Group Ltd. (Nasdaq: DUO) (“FangDD” or the “Company”), a customer-oriented property technology company in China, today announced that it has entered into a convertible note purchase agreement (the “Purchase Agreement”), pursuant to which the Company will issue a convertible promissory note (the “Note”) in a principal amount of US$34,320,000 to an investor through private placement. The Note will be issued to satisfy the Company’s certain payment obligations under an asset purchase agreement dated September 29, 2025 by and between the Company and the investor. Detailed information about the asset purchase agreement can be found in the Company’s current report on Form 6-K furnished to the U.S. Securities and Exchange Commission (the “SEC”) on September 30, 2025. The...

First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune’s ACI-19626 in Precision MedicineAggregated TDP-43 is a pathological hallmark of neurodegenerative diseases including ALS, FTD and LATE, and a co-pathology in Alzheimer’s and Parkinson’s diseases PET imaging of aggregated TDP-43 could facilitate precision medicine in these diseases, whose shared clinical features complicate differential diagnosis, potentially delaying therapy Based on specificity, sensitivity, and pharmacokinetic properties, ACI-19626 was advanced into a Phase 1 clinical study with initial readout expected in Q4 2025Lausanne, Switzerland, October 24, 2025 — AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today...

Company reports 100%+ customer growth in H1 20251 as CEO joins global leaders at FII9 to discuss AI, capital formation, and the future of global trade LONDON, Oct. 24, 2025 (GLOBE NEWSWIRE) — RedCloud Holdings plc (Nasdaq: RCT) (“RedCloud” or the “Company”) the RedAI trading platform used by Fast Moving Consumer Goods (‘FMCG’) businesses, today announced that CEO Justin Floyd will participate in the Future Investment Initiative (FII9) in Riyadh, Saudi Arabia, from October 27–30, 2025. FII9, one of the world’s largest convenings of policymakers, investors, and innovators, brings together more than 600 speakers and global leaders under the theme “The Key to Prosperity: Unlocking New Frontiers of Growth.” Featured participants span finance and technology—including senior executives from Aramco...

TORONTO, Oct. 24, 2025 (GLOBE NEWSWIRE) — Allied Gold Corporation (TSX: AAUC, NYSE: AAUC) (“Allied” or the “Company”) is pleased to announce that it has closed its previously announced overnight marketed public offering of common shares (the “Offering”). Pursuant to the Offering, the Company issued 6,400,000 common shares in the capital of the Company (the “Shares”) at a price of C$27.35 per Share for aggregate gross proceeds of C$175,040,000. The Offering was completed through Stifel Nicolaus Canada Inc., Canaccord Genuity Corp. and National Bank Financial Inc., as joint bookrunners, together with a syndicate of underwriters made up of CIBC World Markets Inc. and Cormark Securities Inc. (together with the joint bookrunners, the “Underwriters”). The Company intends to use the net proceeds of the Offering to i) fund its optimization...

BOWLING GREEN, Ky., Oct. 24, 2025 (GLOBE NEWSWIRE) — Holley Performance Brands (NYSE: HLLY), a leader in automotive aftermarket performance solutions, today announced the date for the release of its third quarter 2025 financial results. Third Quarter 2025 Results        Holley will host a conference call and live webcast on Friday, November 7, 2025, at 8:30 am (Eastern Time) to discuss the Company’s third quarter 2025 financial results. The Company’s earnings release and presentation for the third quarter 2025 will be issued before the market opens on Friday, November 7, 2025, and will be available on the Investor Relations page of the Company’s website at investor.holley.com. Hosting the call will be Holley Inc. President and Chief Executive Officer, Matthew Stevenson, and Chief Financial Officer, Jesse Weaver.Date: Friday,...